NDC 68462-405

ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE

Asprin And Extended-release Dipyridamole

ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., Usa. The primary component is Aspirin; Dipyridamole.

Product ID68462-405_0d676f72-27b7-48b8-aee0-8ce4be845956
NDC68462-405
Product TypeHuman Prescription Drug
Proprietary NameASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
Generic NameAsprin And Extended-release Dipyridamole
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2019-05-24
Marketing CategoryANDA / ANDA
Application NumberANDA210318
Labeler NameGlenmark Pharmaceuticals Inc., USA
Substance NameASPIRIN; DIPYRIDAMOLE
Active Ingredient Strength25 mg/1; mg/1
Pharm ClassesPlatelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 68462-405-30

30 CAPSULE in 1 BOTTLE (68462-405-30)
Marketing Start Date2019-05-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68462-405-60 [68462040560]

ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULE
Marketing CategoryANDA
Application NumberANDA210318
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-05-24

NDC 68462-405-30 [68462040530]

ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULE
Marketing CategoryANDA
Application NumberANDA210318
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-24

Drug Details

Active Ingredients

IngredientStrength
ASPIRIN25 mg/1

Pharmacological Class

  • Cyclooxygenase Inhibitors [MoA]
  • Decreased Prostaglandin Production [PE]
  • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • Decreased Platelet Aggregation [PE]
  • Anti-Inflammatory Agents
  • Non-Steroidal [CS]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.